Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

RIPK3/RIP3 Antibody (1312D) - BSA Free, Novus Biologicals™
SDP

Rabbit Monoclonal Antibody

Supplier:  Novus Biologicals NBP276799

 View more versions of this product

Catalog No. NBP276799


Only null left
Add to Cart

Description

Description

RIPK3/RIP3 Monoclonal specifically detects RIPK3/RIP3 in Human samples. It is validated for Western Blot, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

RIPK3/RIP3
Monoclonal
1.0 mg/mL
Western Blot 2 μ/mL, Immunocytochemistry/Immunofluorescence 5 - 15 μ/mL
EC 2.7.11.1, Receptor Interacting Serine/Threonine Kinase 3, Receptor-interacting protein 3, receptor-interacting serine/threonine-protein kinase 3, receptor-interacting serine-threonine kinase 3, RIP3, RIP-3, RIP-like protein kinase 3
Rabbit
56.7 kDa
Cancer, Cell Biology, Immunology, Necroptosis, Protein Kinase, Signal Transduction
11035
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Western Blot, Immunocytochemistry, Immunofluorescence
1312D
Unconjugated
PBS with 0.02% sodium azide
RIPK3
RIPK3/RIP3 Antibody (1312D) was made to a partial synthetic peptide made to an internal portion of the human RIPK3/RIP3 protein (between amino acids 470-540). This seqeunce has 100% homology to isoform CRA_a and isoform CRA_b.
0.1 mg
Primary
Human
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.